Skip to main content
. 2015 Oct 26;62(4):440–447. doi: 10.1093/cid/civ897

Table 3.

Adverse Events and Laboratory Abnormalities During Treatment Period

Adverse Events Patients, No. (%)
Treatment Naive (n = 25) Treatment Experienced (n = 25)
Any adverse event 25 (100) 25 (100)
 Grade 3 or 4 10 (40) 10 (40)
 Grade 2, 3, or 4 23 (92) 25 (100)
Treatment related 14 (56) 21 (84)
 Grade 3 or 4 2 (8) 1 (4)
 Grade 2, 3, or 4 6 (24) 7 (28)
Serious adverse event 0 (0) 3 (12)
 Treatment related 0 (0) 0 (0)
Deaths 0 (0) 0 (0)